PATENT CLAIM ANALYSIS

Application Number: 15882065
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["514", "017900"]

Abstract:
The disclosure provides for peptides from syndecan 1 and methods of use therefor. These peptides can inhibit VLA-4 interaction with VEGFR2, thereby preventing tumor cell growth and tissue invasion.

Claim (Index 19):
The method of  claim 18 , wherein the cell is within a subject having an inflammatory or autoimmune disease, and whereby the inflammatory or autoimmune disease is treated.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 86.0
- Lexical Diversity: 1.10345
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15043951', '15680423', '13936854', '14688927', '15296218']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.798908195395799
- 35 USC 102 Novelty (BERT): 0.6463740427080931
- Combined Prediction Score: 0.7836547801270285
- Mean Citation Score: 475.912768
- Max Citation Score: 715.2966299999997
- Similarity Product: 543.0786807186483

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test